Hiromu Kondo

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 21

Top Topics

Molecularly Imprinted

Amyotrophic Lateral Sclerosis

Top Venues

Drug development and industrial pharmacy

Pharmaceutical development and technology

AAPS PharmSciTech

This page only lists publications with an associated author ORCID identifier.

Publications

Yusuke Oe, Masanori Kobayashi, Takayuki Yoshida, Hiroyuki Kojima, Takayuki Terukina, Hiromu Kondo
Injectable Testosterone PLGA Microsphere with Different Characteristics: Effect of Preparation Method (Paddle Mixing versus Microfluidic Device). Pharmaceutical development and technology (2024)
Ryota Kimata, Naoki Yoshihara, Yuya Tomita, Takayuki Terukina, Hiromu Kondo
Polymer Characteristics for Drug Layering on Particles Using a Novel Melt Granulation Technology, MALCORE ® . AAPS PharmSciTech 25 (4) (2024)
Ryota Kimata, Naoki Yoshihara, Yuya Tomita, Takayuki Terukina, Hiromu Kondo
Polymer Characteristics for Drug Layering on Particles Using a Novel Melt Granulation Technology, MALCORE ® . AAPS PharmSciTech 25 (4) (2024)
Yusuke Oe, Masanori Kobayashi, Takayuki Yoshida, Hiroyuki Kojima, Takayuki Terukina, Hiromu Kondo
Injectable testosterone PLGA microsphere with different characteristics: effect of preparation method (paddle mixing versus microfluidic device). Pharmaceutical development and technology 29 (5) (2024)
Ryota Kimata, Naoki Yoshihara, Yuya Tomita, Takayuki Terukina, Hiromu Kondo
Polymer Characteristics for Drug Layering on Particles Using a Novel Melt Granulation Technology, MALCORE ® . AAPS PharmSciTech 25 (4) (2024)
Yusuke Oe, Masanori Kobayashi, Takayuki Yoshida, Hiroyuki Kojima, Takayuki Terukina, Hiromu Kondo
Injectable testosterone PLGA microsphere with different characteristics: effect of preparation method (paddle mixing versus microfluidic device). Pharmaceutical development and technology (2024)
Takayuki Terukina, Jun Tanaka, Yumi Takayama, Kaede Osanai, Shusuke Kino, Takanori Kanazawa, Hiromu Kondo
Sangelose-based gels and films: effects of glycerol and α-cyclodextrin and their pharmaceutical application. Drug development and industrial pharmacy 49 (1) (2023)
Takayuki Terukina, Jun Tanaka, Yumi Takayama, Kaede Osanai, Shusuke Kino, Takanori Kanazawa, Hiromu Kondo
Sangelose-based gels and films: effects of glycerol and α-cyclodextrin and their pharmaceutical application. Drug development and industrial pharmacy (2023)
Sorato Ikeda, Masanori Kobayashi, Soken Aoki, Takayuki Terukina, Takanori Kanazawa, Hiroyuki Kojima, Hiromu Kondo
3D-Printed Fast-Dissolving Oral Dosage Forms via Fused Deposition Modeling Based on Sugar Alcohol and Poly(Vinyl Alcohol)-Preparation, Drug Release Studies and In Vivo Oral Absorption. Pharmaceutics 15 (2) (2023)
Sorato Ikeda, Masanori Kobayashi, Soken Aoki, Takayuki Terukina, Takanori Kanazawa, Hiroyuki Kojima, Hiromu Kondo
3D-Printed Fast-Dissolving Oral Dosage Forms via Fused Deposition Modeling Based on Sugar Alcohol and Poly(Vinyl Alcohol)-Preparation, Drug Release Studies and In Vivo Oral Absorption. Pharmaceutics 15 (2) (2023)
Takayuki Terukina, Jun Tanaka, Yumi Takayama, Kaede Osanai, Shusuke Kino, Takanori Kanazawa, Hiromu Kondo
Sangelose-based gels and films: effects of glycerol and α-cyclodextrin and their pharmaceutical application. Drug development and industrial pharmacy (2023)
Takayuki Terukina, Jun Tanaka, Yumi Takayama, Kaede Osanai, Shusuke Kino, Takanori Kanazawa, Hiromu Kondo
Sangelose-based gels and films: effects of glycerol and α-cyclodextrin and their pharmaceutical application. Drug development and industrial pharmacy 49 (1) (2023)
Sorato Ikeda, Masanori Kobayashi, Soken Aoki, Takayuki Terukina, Takanori Kanazawa, Hiroyuki Kojima, Hiromu Kondo
3D-Printed Fast-Dissolving Oral Dosage Forms via Fused Deposition Modeling Based on Sugar Alcohol and Poly(Vinyl Alcohol)-Preparation, Drug Release Studies and In Vivo Oral Absorption. Pharmaceutics 15 (2) (2023)
Sorato Ikeda, Masanori Kobayashi, Soken Aoki, Takayuki Terukina, Takanori Kanazawa, Hiroyuki Kojima, Hiromu Kondo
3D-Printed Fast-Dissolving Oral Dosage Forms via Fused Deposition Modeling Based on Sugar Alcohol and Poly(Vinyl Alcohol)-Preparation, Drug Release Studies and In Vivo Oral Absorption. Pharmaceutics 15 (2) (2023)
Takayuki Yoshida, Hiroyuki Kojima, Kazuhiro Sako, Hiromu Kondo
Drug delivery to the intestinal lymph by oral formulations. Pharmaceutical development and technology 27 (2) (2022)
Momoka Yamaguchi, Takanori Kanazawa, Sumire Morino, Shingo Iioka, Yuta Watanabe, Naoki Dohi, Kenjirou Higashi, Hiromu Kondo, Tomohisa Ishikawa
Increased Tropism of Extracellular Vesicles Derived from Palmitic Acid-Treated Hepatocytes to Activated Hepatic Stellate Cells. Membranes 12 (10) (2022)
Takumi Kurano, Takanori Kanazawa, Shingo Iioka, Hiromu Kondo, Yasuhiro Kosuge, Toyofumi Suzuki
Intranasal Administration of N -acetyl-L-cysteine Combined with Cell-Penetrating Peptide-Modified Polymer Nanomicelles as a Potential Therapeutic Approach for Amyotrophic Lateral Sclerosis. Pharmaceutics 14 (12) (2022)
Takumi Kurano, Takanori Kanazawa, Shingo Iioka, Hiromu Kondo, Yasuhiro Kosuge, Toyofumi Suzuki
Intranasal Administration of N -acetyl-L-cysteine Combined with Cell-Penetrating Peptide-Modified Polymer Nanomicelles as a Potential Therapeutic Approach for Amyotrophic Lateral Sclerosis. Pharmaceutics 14 (12) (2022)
Takumi Kurano, Takanori Kanazawa, Shingo Iioka, Hiromu Kondo, Yasuhiro Kosuge, Toyofumi Suzuki
Intranasal Administration of N -acetyl-L-cysteine Combined with Cell-Penetrating Peptide-Modified Polymer Nanomicelles as a Potential Therapeutic Approach for Amyotrophic Lateral Sclerosis. Pharmaceutics 14 (12) (2022)
Takumi Kurano, Takanori Kanazawa, Shingo Iioka, Hiromu Kondo, Yasuhiro Kosuge, Toyofumi Suzuki
Intranasal Administration of N -acetyl-L-cysteine Combined with Cell-Penetrating Peptide-Modified Polymer Nanomicelles as a Potential Therapeutic Approach for Amyotrophic Lateral Sclerosis. Pharmaceutics 14 (12) (2022)
Takayuki Yoshida, Kazuhiro Sako, Hiromu Kondo
Design of novel tacrolimus formulations with chemically synthesized oils for oral lymphatic delivery. Drug development and industrial pharmacy 46 (2) (2020)